See All Slides - tctmd.com

Slides

Presentation TCT 2014

Case #7: In-Stent Restenosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Bernhard Witzenbichler

September 15, 2014

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

Presentation TCT 2014

Keystone Deflector Device - Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Presenter: Alexandra J. Lansky

September 15, 2014

Presentation TCT 2014

First Use of an Objective and Reproducible Method for Quantification of Aortic Regurgitation After TAVR Based on Angiography

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Carl Schultz

September 15, 2014

Presentation TCT 2014

Is There a Role for a Dedicated Bifurcation Stent Device? Landscape and Lessons from the Tryton Trial

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Antonio L. Bartorelli

September 15, 2014

Presentation TCT 2014

FOCUS np: Clinical and Angiographic Results with a Nanoparticle-Based Siroliumus-Eluting Stent and Balloon

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Upendra Kaul

September 15, 2014

Presentation TCT 2014

Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Louis B. Jacques

September 15, 2014

Presentation TCT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

September 15, 2014

Presentation TCT 2014

TCT 151: Transcatheter Transplantation and In Vivo Tracking Of Human Stem Cell-Based 3-Dimensional Microtissues in a Porcine Model Of Myocardial Infarction

Presenter: Warren Sherman, Wojtek Wojakowski, Stephen E. Epstein, Maximilian Y Emmert

September 15, 2014

Presentation TCT 2014

TCT 151: Transcatheter Transplantation and In Vivo Tracking Of Human Stem Cell-Based 3-Dimensional Microtissues in a Porcine Model Of Myocardial Infarction

Presenter: Warren Sherman, Wojtek Wojakowski, Stephen E. Epstein, Maximilian Y Emmert

September 15, 2014

Advertisement

Slides

Case #7: In-Stent Restenosis

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Keystone Deflector Device - Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

First Use of an Objective and Reproducible Method for Quantification of Aortic Regurgitation After TAVR Based on Angiography

Is There a Role for a Dedicated Bifurcation Stent Device? Landscape and Lessons from the Tryton Trial

FOCUS np: Clinical and Angiographic Results with a Nanoparticle-Based Siroliumus-Eluting Stent and Balloon

Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

TCT 151: Transcatheter Transplantation and In Vivo Tracking Of Human Stem Cell-Based 3-Dimensional Microtissues in a Porcine Model Of Myocardial Infarction

TCT 151: Transcatheter Transplantation and In Vivo Tracking Of Human Stem Cell-Based 3-Dimensional Microtissues in a Porcine Model Of Myocardial Infarction

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content